GlassScriptPhysician profile
William A Clark
NPI 1265888937
$867.49
in general payments reported to CMS, 2019-2025
15 companies · $14.30 in 2025
The $14.30 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.56 · 2021: $19.86 · 2022: $385 · 2023: $270 · 2024: $149 · 2025: $14.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $195.72 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Convatec INC. | $161.72 | 2023-2024 | |
| Depuy Synthes Sales INC. | $122.83 | 2022-2024 | Minibunion |
| Treace Medical Concepts, INC. | $64.41 | 2022-2023 | |
| Averitas Pharma INC. | $51.55 | 2023-2024 | Qutenza |
| Ossio INC | $49.90 | 2022 | |
| Nevro Corp. | $38.26 | 2021-2022 | |
| Abbott Laboratories | $35.64 | 2024-2025 | Proclaim, Eterna |
| Smith+Nephew, INC. | $28.54 | 2022-2023 | Collagenase Santyl, Regranex |
| Abbvie INC. | $24.57 | 2022 | |
| Organogenesis INC. | $24.38 | 2023 | Puraply |
| Novastep INC. | $22.27 | 2023 | Creed Ortholocent Implants |
| Horizon Therapeutics Plc | $20.44 | 2022 | |
| Paragon 28, INC. | $14.12 | 2020 | |
| Orthofix Medical, INC. | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.